Skip to main content
STAT+: Pharmalittle: We’re reading about cheap generic obesity drugs in India, high demand for estrogen patches and more
Pricing Updates April 12, 2026

STAT+: Pharmalittle: We’re reading about cheap generic obesity drugs in India, high demand for estrogen patches and more

This article from STAT News covers: STAT+: Pharmalittle: We’re reading about cheap generic obesity drugs in India, high demand for estrogen patches and more.

Source: STAT News • Editorial summary by GLP-1 Price Guide

What This Means for You

This article from STAT News covers: STAT+: Pharmalittle: We’re reading about cheap generic obesity drugs in India, high demand for estrogen patches and more.

This article from STAT News covers: STAT+: Pharmalittle: We’re reading about cheap generic obesity drugs in India, high demand for estrogen patches and more.

Source: STAT News

Keep Reading

Original source

Read the full article at STAT News

More News

Drug News

FDA approves Lilly's Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions

Apr 13 Drug News

Foundayo™ (orforglipron), Lilly's new oral GLP-1 pill for weight loss, now available in the U.S.

Apr 13 Drug News

Media Statement: Zepbound (tirzepatide) KwikPen now available at self-pay pricing at major pharmacies nationwide in addition to LillyDirect

Apr 12